Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 5
1966 5
1967 10
1968 14
1969 19
1970 14
1971 16
1972 17
1973 14
1974 12
1975 21
1976 24
1977 19
1978 18
1979 13
1980 14
1981 12
1982 19
1983 28
1984 40
1985 48
1986 43
1987 45
1988 50
1989 68
1990 59
1991 84
1992 74
1993 82
1994 130
1995 119
1996 161
1997 129
1998 148
1999 154
2000 162
2001 146
2002 147
2003 175
2004 181
2005 195
2006 221
2007 233
2008 214
2009 221
2010 230
2011 245
2012 253
2013 249
2014 225
2015 278
2016 291
2017 300
2018 272
2019 265
2020 285
2021 331
2022 258
2023 235
2024 224
2025 66

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,813 results

Results by year

Filters applied: . Clear all
Page 1
Prednisolone Versus Dexamethasone for Croup: a Randomized Controlled Trial.
Parker CM, Cooper MN. Parker CM, et al. Pediatrics. 2019 Sep;144(3):e20183772. doi: 10.1542/peds.2018-3772. Epub 2019 Aug 15. Pediatrics. 2019. PMID: 31416827 Clinical Trial.
In this study, we compare dexamethasone at 0.6 mg/kg with both low-dose dexamethasone at 0.15 mg/kg and prednisolone at 1 mg/kg. ...Re-attendance rates were 17.8% for dexamethasone, 19.5% for low-dose dexamethasone, and 21.7% for prednisolone (not sign …
In this study, we compare dexamethasone at 0.6 mg/kg with both low-dose dexamethasone at 0.15 mg/kg and prednisolone at 1 mg/k …
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
Richardson PG, Trudel S, Popat R, Mateos MV, Vangsted AJ, Ramasamy K, Martinez-Lopez J, Quach H, Orlowski RZ, Arnao M, Lonial S, Karanes C, Pawlyn C, Kim K, Oriol A, Berdeja JG, Rodríguez Otero P, Casas-Avilés I, Spirli A, Poon J, Li S, Gong J, Wong L, Lamba M, Pierce DW, Amatangelo M, Peluso T, Maciag P, Katz J, Pourdehnad M, Bahlis NJ; CC-92480-MM-001 Study Investigators. Richardson PG, et al. N Engl J Med. 2023 Sep 14;389(11):1009-1022. doi: 10.1056/NEJMoa2303194. Epub 2023 Aug 30. N Engl J Med. 2023. PMID: 37646702 Clinical Trial.
METHODS: In this phase 1-2 study, we administered oral mezigdomide in combination with dexamethasone to patients with relapsed and refractory myeloma. The primary objectives of phase 1 (dose-escalation cohort) were to assess safety and pharmacokinetics and to identify the …
METHODS: In this phase 1-2 study, we administered oral mezigdomide in combination with dexamethasone to patients with relapsed and re …
Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB; DART Study Investigators. Doyle LW, et al. Pediatrics. 2006 Jan;117(1):75-83. doi: 10.1542/peds.2004-2843. Pediatrics. 2006. PMID: 16396863 Clinical Trial.
There was little evidence for a reduction in either the mortality rate (dexamethasone group: 11%; control group: 20%; OR: 0.52; 95% CI: 0.14-1.95) or the rate of oxygen dependence at 36 weeks (dexamethasone group: 85%; control group: 91%; OR: 0.58; 95% CI: 0.13-2.66 …
There was little evidence for a reduction in either the mortality rate (dexamethasone group: 11%; control group: 20%; OR: 0.52; 95% C …
Intraoperative dexamethasone and chronic postsurgical pain: a propensity score-matched analysis of a large trial.
Myles PS, Corcoran TB, Chan MT, Asghari-Jafarabadi M, Wu WKK, Peyton P, Leslie K, Forbes A. Myles PS, et al. Br J Anaesth. 2024 Jul;133(1):103-110. doi: 10.1016/j.bja.2023.12.031. Epub 2024 Jan 24. Br J Anaesth. 2024. PMID: 38267338 Clinical Trial.
RESULTS: We analysed 2999 patients, of whom 116 of 973 (11.9%) receiving dexamethasone reported CPSP, and 380 of 2026 (18.8%) not receiving dexamethasone reported CPSP, unadjusted odds ratio 0.76 (95% confidence interval 0.78-1.00), P=0.052. After propensity score m …
RESULTS: We analysed 2999 patients, of whom 116 of 973 (11.9%) receiving dexamethasone reported CPSP, and 380 of 2026 (18.8%) not rec …
Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial.
Dastenae ZH, Bahadori A, Dehghani M, Asadi-Samani M, Izadi I, Shahraki HR. Dastenae ZH, et al. Int J Infect Dis. 2022 Sep;122:659-664. doi: 10.1016/j.ijid.2022.07.019. Epub 2022 Jul 9. Int J Infect Dis. 2022. PMID: 35817286 Free PMC article. Clinical Trial.
OBJECTIVE: In this study, we aimed to compare the effects of intravenous dexamethasone and methylprednisolone on the treatment of inpatients with COVID-19. METHODS: In this randomized clinical trial, 143 patients under 80 years of age with moderate to severe COVID-19 were …
OBJECTIVE: In this study, we aimed to compare the effects of intravenous dexamethasone and methylprednisolone on the treatment of inp …
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial.
Toroghi N, Abbasian L, Nourian A, Davoudi-Monfared E, Khalili H, Hasannezhad M, Ghiasvand F, Jafari S, Emadi-Kouchak H, Yekaninejad MS. Toroghi N, et al. Pharmacol Rep. 2022 Feb;74(1):229-240. doi: 10.1007/s43440-021-00341-0. Epub 2021 Nov 27. Pharmacol Rep. 2022. PMID: 34837648 Free PMC article. Clinical Trial.
The goals of the present study were to compare the efficacy and safety of different doses of dexamethasone in the treatment of patients with a diagnosis of moderate to severe COVID-19. ...CONCLUSIONS: Higher doses of dexamethasone not only failed to improve efficacy …
The goals of the present study were to compare the efficacy and safety of different doses of dexamethasone in the treatment of patien …
Comparison of the Efficacy of Dexamethasone and Methylprednisolone in Infiltration Injection for Postendodontic Pain in Patients with Necrotic Pulp: A Randomized Controlled Clinical Trial.
Yeganegi S, Fazelian N, Layegh Nejad MK, Manzouri L. Yeganegi S, et al. Pain Res Manag. 2022 Feb 23;2022:4163120. doi: 10.1155/2022/4163120. eCollection 2022. Pain Res Manag. 2022. PMID: 35251416 Free PMC article. Clinical Trial.
This clinical study aimed to evaluate the effect of infiltration injection of dexamethasone and methylprednisolone on postendodontic pain in patients with necrotic pulp. ...CONCLUSIONS: Infiltration injection of dexamethasone and methylprednisolone had a significant …
This clinical study aimed to evaluate the effect of infiltration injection of dexamethasone and methylprednisolone on postendodontic …
Chikungunya Arthritis Treatment with Methotrexate and Dexamethasone: A Randomized, Double-blind, Placebo-controlled Trial.
Amaral JK, Lucena G, Schoen RT. Amaral JK, et al. Curr Rheumatol Rev. 2024;20(3):337-346. doi: 10.2174/0115733971278715231208114037. Curr Rheumatol Rev. 2024. PMID: 38173199 Clinical Trial.
OBJECTIVE: This study aimed to evaluate the efficacy and safety of treatment of chronic chikungunya arthritis with methotrexate and dexamethasone in a randomized, double-blind, placebo-controlled clinical trial. METHODS: The patients were reassessed for treatment response …
OBJECTIVE: This study aimed to evaluate the efficacy and safety of treatment of chronic chikungunya arthritis with methotrexate and dexam …
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Zielen S, Crawford T, Benatti L, Magnani M, Kieslich M, Ryan M, Meyts I, Gulati S, Borgohain R, Yadav R, Pal P, Hegde A, Kumar S, Venkateswar A, Udani V, Vinayan KP, Nissenkorn A, Fazzi E, Leuzzi V, Stray-Pedersen A, Pietrucha B, Pascual SI, Gouider R, Koenig MK, Wu S, Perlman S, Thye D, Janhofer G, Horn B, Whitehouse W, Lederman H. Zielen S, et al. Lancet Neurol. 2024 Sep;23(9):871-882. doi: 10.1016/S1474-4422(24)00220-5. Lancet Neurol. 2024. PMID: 39152028 Clinical Trial.
The aim of the ATTeST study was to evaluate the efficacy and safety of intra-erythrocyte delivery of dexamethasone sodium phosphate compared with placebo in children with ataxia telangiectasia. ...One patient assigned to high-dose intra-erythrocyte dexamethasone sod …
The aim of the ATTeST study was to evaluate the efficacy and safety of intra-erythrocyte delivery of dexamethasone sodium phosphate c …
Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial.
Wu H, Daouk S, Kebbe J, Chaudry F, Harper J, Brown B. Wu H, et al. PLoS One. 2022 Oct 3;17(10):e0275217. doi: 10.1371/journal.pone.0275217. eCollection 2022. PLoS One. 2022. PMID: 36190994 Free PMC article. Clinical Trial.
The evidence on the benefit of high-dose dexamethasone is limited. The goal of this study was to assess the effects of 6 mg daily vs. 20 mg daily of dexamethasone in hospitalized patients with COVID-19 pneumonia. ...Participants were randomized 1:1 to dexamethaso …
The evidence on the benefit of high-dose dexamethasone is limited. The goal of this study was to assess the effects of 6 mg daily vs. …
6,813 results